TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -1 | -1 | 3 | 4 | -11 | -19 | -4 |
| P | %wins | 0 | 0 | 100 | 100 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/25 16:30 | 5/2/25 | BLCO | Bausch & Lomb Corp | Health | OthMd | Ophthalmic Goods | Von Eschenbach Andrew C. | A6 | D | P | 20 | 11.76 | 0 | 2 | 4 | 42 | D | ||||||||||||||||
12/2/21 21:44 | 11/9/21 | CELU | Celularity Inc | DE | Health | Drug | Pharmaceutical Preparations | Von Eschenbach Andrew C. | NJ | D | M.d | 28 | 0.2800 | 0 | 100 | New | 100 | D | |||||||||||||||
8/9/21 16:13 | 8/5/21 | BHC | Bausch Health Companies Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Von Eschenbach Andrew C. | NJ | D | P | 36 | 25.94 | 0 | 1 | 4 | 39 | D | |||||||||||||||
3/11/20 20:50 | 3/10/20 | BHC | Bausch Health Companies Inc. | NJ | Health | Drug | Pharmaceutical Preparations | Von Eschenbach Andrew C. | NJ | D | P | 20 | 18.18 | 0 | 1 | 6 | 19 | D | |||||||||||||||
8/14/13 18:04 | 8/12/13 | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | Von Eschenbach Andrew C. | TX | D | P.d | 11 | 3.69 | 0 | 3 | New | 3 | D | -16 | -3 | -11 | -9 | -8 | -4 | -5 | 2 | -1 | -1 | 3 | 4 | -11 | -19 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |